Chicago, IL – AltaThera Pharmaceuticals has recently partnered with Rush University Medical Center to support arrhythmia research around the world. Through a charitable donation of the medication IV Sotalol (sotalol hydrochloride injection 15mg/mL for intravenous use), AltaThera is supporting important research regarding prophylaxis for post-op dysrhythmias. The research is scheduled to take place at Hanoi Heart Hospital in Hanoi, Vietnam over the course of 2019/2020.
CHICAGO – AltaThera Pharmaceuticals is among 10 Chicago companies chosen to launch MATTER, an organization of healthcare innovators developed to promote innovation and collaboration among the city’s leading health care and pharmaceutical entrepreneurs.
